Y-mabs Therapeutics, Inc.
YMAB
Revenue
22.80M
▲2.87M▲14.38%
3 Months ChangeAssets
144.04M
▲20.72M▲16.80%
3 Months ChangeLiabilities
48.70M
▲24.57M▲101.85%
3 Months ChangeFree Cash Flow
-32.26M
▼-10.48M▼-48.11%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001558370-24-012925
2024-09-17
Form 8-K
ID: 0001558370-24-012850
2024-08-12
Form 10-Q
ID: 0001558370-24-011795
2024-08-12
Form 8-K
ID: 0001558370-24-011792
2024-07-19
Form 8-K
ID: 0001558370-24-009915
2024-07-01
Form 8-K
ID: 0001558370-24-009643
2024-06-28
Form 8-K
ID: 0001558370-24-009614
2024-06-13
Form 8-K
ID: 0001104659-24-071250
2024-05-07
Form 10-Q
ID: 0001558370-24-007056
2024-05-07
Form 8-K
ID: 0001558370-24-007047